BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19054166)

  • 1. Discrepancies between cytology, cystoscopy and biopsy in bladder cancer detection after Bacille Calmette-Guerin intravesical therapy.
    Hara T; Takahashi M; Gondo T; Nagao K; Ohmi C; Sakano S; Naito K; Matsuyama H
    Int J Urol; 2009 Feb; 16(2):192-5. PubMed ID: 19054166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urothelial bladder biopsy--important evolution prognosis factor of superficial bladder cancer under intravesical Bacille Calmette-Guérin therapy.
    Geavlete P; Taşcă C
    Rom J Morphol Embryol; 1991; 37(1-2):61-8. PubMed ID: 1801981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of carcinoma in situ under intravesical Romanian Bacille Calmette-Guérin therapy.
    Geavlete P; Taşcă C
    Rom J Morphol Embryol; 1991; 37(1-2):69-74. PubMed ID: 1801982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intravesical Bacillus Calmette-Guérin on detection of a urothelial differentiation antigen in exfoliated cells of carcinoma in situ of the human urinary bladder.
    Huffman JL; Fradet Y; Cordon-Cardo C; Herr HW; Pinsky CM; Oettgen HF; Old LJ; Whitmore WF; Melamed MR
    Cancer Res; 1985 Oct; 45(10):5201-4. PubMed ID: 4027997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of bladder carcinoma in females by flow cytometry and cytology.
    Hermansen DK; Badalament RA; Fair WR; Kimmel M; Whitmore WF; Melamed MR
    Cytometry; 1989 Nov; 10(6):739-42. PubMed ID: 2582965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacillus Calmette-Guérin-treated superficial bladder cancer: correlation of morphology with immunophenotyping.
    Leong AS; Wannakrairot P; Jose J; Milios J
    J Pathol; 1990 Sep; 162(1):35-41. PubMed ID: 2231190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring intravesical bacillus Calmette-Guerin treatment of superficial bladder carcinoma by serial flow cytometry.
    Badalament RA; Gay H; Whitmore WF; Herr HW; Fair WR; Oettgen HF; Melamed MR
    Cancer; 1986 Dec; 58(12):2751-7. PubMed ID: 3779622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitomycin for patients who have failed on thiotepa. The National Bladder Cancer Group.
    Koontz WW; Heney NM; Soloway MS; Kluskens L; Hazra TA; Trump DL; Barton B
    Urology; 1985 Oct; 26(4 Suppl):30-1. PubMed ID: 3931326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of cytological examination for postoperative bladder cancer].
    Kawachi Y
    Hinyokika Kiyo; 1983 Nov; 29(11):1469-74. PubMed ID: 6677099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Urine cytology as a supplement to cystoscopy and biopsy in the control of bladder tumors].
    Andersen OP; Ladefoged C; Røhl HF; Osther P; Holm K
    Ugeskr Laeger; 1989 Dec; 151(50):3400-1. PubMed ID: 2609449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Follow-up cytology in the management of urotheliomas].
    Kawachi Y; Iwata S; Takahashi S; Ogawa Y; Kitagawa R
    Hinyokika Kiyo; 1986 Apr; 32(4):527-31. PubMed ID: 3739859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometry as a predictor of response and progression in patients with superficial bladder cancer treated with bacillus Calmette-Guerin.
    Bretton PR; Herr HW; Kimmel M; Fair WR; Whitmore WF; Melamed MR
    J Urol; 1989 Jun; 141(6):1332-6. PubMed ID: 2724430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of exfoliative cytology of the urinary bladder in occult bladder cancer and in the control of treated cancers].
    Schmitz A; Meyer U; Kierfeld G; Küchemann K
    Urologe A; 1984 Sep; 23(5):278-80. PubMed ID: 6542269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic value of flow cytometry of bladder lavage in the surveillance of bladder tumors].
    Hijazi A; Devonec M; Muchada E; Dubernard JM; Revillard JP
    J Urol (Paris); 1987; 93(1):11-20. PubMed ID: 3559255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Various staining procedures in exfoliative urine cytology. Use in routine urology].
    Rübben H; Terhorst B; Deutz FJ; Lagrange W; Giani G
    Urologe A; 1986 Sep; 25(5):302-4. PubMed ID: 2431532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunophenotypic characterization of the bladder mucosa infiltrating lymphocytes after intravesical BCG treatment for superficial bladder carcinoma.
    Boccafoschi C; Montefiore F; Pavesi M; Pastormerlo M; Annoscia S; Lozzi C; Betta PG
    Eur Urol; 1992; 21(4):304-8. PubMed ID: 1459153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytologic detection of urothelial cancer and other abnormalities in a cohort of workers exposed to aromatic amines.
    Crosby JH; Allsbrook WC; Koss LG; Bales CE; Witherington R; Schulte PA; Hemstreet G; Ringer K
    Acta Cytol; 1991; 35(3):263-8. PubMed ID: 2042428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytohistologic correlation of urothelial lesions secondary to photodynamic therapy.
    Broghamer WL; Parker JE; Harty JI; Gilkey CM
    Acta Cytol; 1989; 33(6):881-6. PubMed ID: 2531527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The value of urinary cytology in the diagnosis and follow-up of patients with primary bladder tumors].
    Ioiart I; Gurtavenco A; Raica M
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1989; 38(3):173-7. PubMed ID: 2529583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinoma in situ of the bladder.
    Herr HW
    Semin Urol; 1983 Feb; 1(1):15-22. PubMed ID: 6679095
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.